Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Autoimmune Diseases
>>
CD20
>>
Phase 2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
PF-5230895
/ Emergent Biosolutions, Pfizer
Rixathon
(rituximab biosimilar) / Kyowa Kirin, Sandoz
Ruxience
(rituximab-pvvr) / Pfizer
TRU-015
/ Pfizer
Veltucyn
(veltuzumab) / Gilead
